Investigation of the migration of triclabendazole residues to milk products manufactured from bovine milk, and stability therein, following lactating cow treatment.

@article{Power2013InvestigationOT,
  title={Investigation of the migration of triclabendazole residues to milk products manufactured from bovine milk, and stability therein, following lactating cow treatment.},
  author={Clare H. Power and Martin Danaher and Riona Sayers and Barry O'brien and Clare Clancy and Ambrose Furey and Kieran Jordan},
  journal={Journal of dairy science},
  year={2013},
  volume={96 10},
  pages={
          6223-32
        }
}
Triclabendazole (TCB) is a flukicide used in the treatment of liver fluke in cattle; however, its use is currently prohibited in lactating dairy cows. In this study, following administration of 10% Fasinex (triclabendazole, Novartis Animal Health UK Ltd., Camberley, UK) the milk of 6 animals was used to manufacture dairy products, to ascertain if TCB residues in milk migrate into dairy products. The detection limit of the ultra-high-performance liquid chromatography-tandem mass spectrometry… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

References

Publications referenced by this paper.
SHOWING 1-10 OF 36 REFERENCES

European public MRL assessment report (EPMAR) Triclabendazole (extrapolation to bovine and ovine milk) EMA/CVMP/8136/2011

  • European Medicines Agency.
  • European Medicines Agency, London, UK.
  • 2012

Fasinex 240: Summary of product characteristics

  • Irish Medicine Board.
  • Accessed Jan. 18, . http://www.imb.ie/images…
  • 2012

Liver fluke: The facts

  • Animal Health Ireland.
  • Parasites Leaflet Number 5, Version 1 July…
  • 2011

Similar Papers

Loading similar papers…